SCHEMBL13355348

SCHEMBL13355348

CCOc1c(NCc2ccc(Cl)c(Cl)c2)c(=O)c1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK2 P49760 2/20 0.52
DYRK1A Q13627 2/20 0.52
CLK4 Q9HAZ1 2/20 0.52
CHEK1 O14757 1/20 0.52
ROCK2 O75116 1/20 0.52
RPS6KA5 O75582 1/20 0.52
MAP4K4 O95819 1/20 0.52
CHEK2 O96017 1/20 0.52
PIM1 P11309 1/20 0.52
PRKACA P17612 1/20 0.52
RPS6KB1 P23443 1/20 0.52
MAPK1 P28482 1/20 0.52
AKT1 P31749 1/20 0.52
AKT2 P31751 1/20 0.52
GSK3A P49840 1/20 0.52
GSK3B P49841 1/20 0.52
RPS6KA3 P51812 1/20 0.52
PRKX P51817 1/20 0.52
NEK4 P51957 1/20 0.52
CSNK1G2 P78368 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7895007 0.85 CHEK1 (0.41) CLK2DYRK1ACLK4CHEK1ROCK2
SCHEMBL22320268 0.78 GAA (0.50) MAPK1ALDH1A1POLBGAAMAPT
SCHEMBL9208078 0.78 GAA (0.52) SMN1; SMN2ALDH1A1POLBGAAMAPT
SCHEMBL7894007 0.76 POLB (0.37) ROCK2CHEK2PRKACARPS6KB1MAPK1
SCHEMBL12092541 0.75 CHEK2 (0.49) CLK2DYRK1ACLK4CHEK1ROCK2
SCHEMBL7599186 0.75 CHEK2 (0.55) CLK2DYRK1ACLK4CHEK1ROCK2
SCHEMBL7895099 0.75 LOXL2 (0.46) CLK4CHEK1CHEK2PRKACARPS6KB1
SCHEMBL31155173 0.75 MAPT (0.50) SMN1; SMN2ALDH1A1POLBGAAMAPT
SCHEMBL7603199 0.74 CHEK2 (0.58) CLK2DYRK1ACLK4CHEK1ROCK2
SCHEMBL7597388 0.74 CHEK2 (0.54) CLK2DYRK1ACLK4CHEK1ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010057101-A2 COMPOUNDS USEFUL AS HIV BLOCKERS SCHERING CORPORATION (US) 2010-05-20 WO disclosed